Literature DB >> 17099007

Increased COPD among HIV-positive compared to HIV-negative veterans.

Kristina Crothers1, Adeel A Butt, Cynthia L Gibert, Maria C Rodriguez-Barradas, Stephen Crystal, Amy C Justice.   

Abstract

BACKGROUND: Limited data prior to highly active antiretroviral therapy (HAART) suggested the possibility of an increased risk of COPD among those persons with HIV infection. We sought to determine whether HIV infection is associated with increased prevalence of COPD in the era of HAART.
METHODS: Prospective observational study of 1,014 HIV-positive and 713 HIV-negative men who were enrolled in the Veterans Aging Cohort 5 Site Study. COPD was determined by patient self-report and International Classification of Diseases, ninth revision (ICD-9), diagnostic codes. Cigarette smoking and injection drug use (IDU) were determined by self-report, and alcohol abuse was determined by ICD-9 diagnostic codes. Laboratory and pharmacy data were obtained from electronic medical records.
RESULTS: The prevalence of COPD as determined by ICD-9 codes was 10% in HIV-positive subjects and 9% in HIV-negative subjects (p = 0.4), and as determined by patient self-report was 15% and 12%, respectively (p = 0.04). After adjusting for age, race/ethnicity, pack-years of smoking, IDU, and alcohol abuse, HIV infection was an independent risk factor for COPD. HIV-infected subjects were approximately 50 to 60% more likely to have COPD than HIV-negative subjects (by ICD-9 codes: odds ratio [OR], 1.47; 95% confidence interval [CI], 1.01 to 2.13; p = 0.04 ; by patient self-report: OR, 1.58; 95% CI, 1.14 to 2.18; p = 0.005).
CONCLUSIONS: HIV infection was an independent risk factor for COPD, when determined either by ICD-9 codes or patient self-report. Health-care providers should be aware of the increased likelihood of COPD among their HIV-positive patients. The possibility that HIV infection increases susceptibility to and/or accelerates COPD deserves further investigation and has implications regarding the pathogenesis of COPD.

Entities:  

Mesh:

Year:  2006        PMID: 17099007     DOI: 10.1378/chest.130.5.1326

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  181 in total

1.  Persistent pneumocystis colonization leads to the development of chronic obstructive pulmonary disease in a nonhuman primate model of AIDS.

Authors:  Timothy W Shipley; Heather M Kling; Alison Morris; Sangita Patil; Jan Kristoff; Siobhan E Guyach; Jessica E Murphy; Xiuping Shao; Frank C Sciurba; Robert M Rogers; Thomas Richards; Paul Thompson; Ronald C Montelaro; Harvey O Coxson; James C Hogg; Karen A Norris
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

2.  Experimental Pneumocystis lung infection promotes M2a alveolar macrophage-derived MMP12 production.

Authors:  Michael P Nelson; Benjamin S Christmann; Chad W Dunaway; Alison Morris; Chad Steele
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-06       Impact factor: 5.464

3.  The new epidemic of non-communicable disease in people living with the human immunodeficiency virus.

Authors:  R Dawson; W N Rom; K Dheda; E D Bateman
Journal:  Public Health Action       Date:  2013-03-21

Review 4.  The epidemiology of substance use disorders in US Veterans: A systematic review and analysis of assessment methods.

Authors:  Chiao-Wen Lan; David A Fiellin; Declan T Barry; Kendall J Bryant; Adam J Gordon; E Jennifer Edelman; Julie R Gaither; Stephen A Maisto; Brandon D L Marshall
Journal:  Am J Addict       Date:  2015-12-22

5.  Adolescent age is an independent risk factor for abnormal spirometry among people living with HIV in Kenya.

Authors:  Engi F Attia; Elizabeth Maleche-Obimbo; T Eoin West; Lilian Ndukwe-Wambutsi; Catherine Kiptinness; Anthony Cagle; Christine J McGrath; Celestine K Mugambi; Neveen G El Antouny; Sherry Eskander; Michael H Chung; Kristina Crothers
Journal:  AIDS       Date:  2018-06-19       Impact factor: 4.177

Review 6.  Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD.

Authors:  R N van Zyl Smit; M Pai; W W Yew; C C Leung; A Zumla; E D Bateman; K Dheda
Journal:  Eur Respir J       Date:  2010-01       Impact factor: 16.671

7.  Commentary: Treated HIV infection is a chronic disease: the case against cause of death analyses.

Authors:  Amy C Justice
Journal:  Int J Epidemiol       Date:  2009-11-09       Impact factor: 7.196

8.  Current cigarette smoking among HIV-positive current and former drug users: associations with individual and social characteristics.

Authors:  Lauren R Pacek; Carl Latkin; Rosa M Crum; Elizabeth A Stuart; Amy R Knowlton
Journal:  AIDS Behav       Date:  2014-07

9.  Cigarette smoke and HIV synergistically affect lung pathology in cynomolgus macaques.

Authors:  Hitendra S Chand; Rodrigo Vazquez-Guillamet; Christopher Royer; Karin Rudolph; Neerad Mishra; Shashi P Singh; Shah S Hussain; Edward Barrett; Shannon Callen; Siddappa N Byrareddy; Maria Cristina Vazquez Guillamet; Jawad Abukhalaf; Aryaz Sheybani; Vernat Exil; Veena Raizada; Hemant Agarwal; Madhavan Nair; Francois Villinger; Shilpa Buch; Mohan Sopori
Journal:  J Clin Invest       Date:  2018-11-05       Impact factor: 14.808

10.  Women, Aging, and HIV: Clinical Issues and Management Strategies.

Authors:  Julie A Womack; Cynthia A Brandt; Amy C Justice
Journal:  J Nurse Pract       Date:  2014-06-01       Impact factor: 0.767

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.